Pharma Pressreleases

This section covers the managerial aspects in the Pharma industry.

The Bitter Truth About Sugar!

Wednesday, November 30, 2016

Business Wire IndiaOn average an individual having three square meals a day consumes up to 148 grams of sugar Today sugar is a pervasive element of our diet in spite of it being linked to various heart diseases as well as an increased risk of diabetes The World Health Organization recommends cutting..

The Future of Parallel Trade: EU Falsified Medicine Directive, Legal Issues, Parallel Distribution, Anti-Counterfeiting, Regional Focus.

Wednesday, November 30, 2016

With Brexit and the new EU Falsified Medicine Directive what does the future hold for parallel trade Over 90 senior leaders in parallel trade will meet in London in February 2017 to discuss upcoming trends and share best practices The Falsified Medicines Directive introduces tough directives to imp..

Mats Wahlström Joins Surefire Medical Board of Directors

Wednesday, November 30, 2016
GLOBE NEWSWIRE

WESTMINSTER Colo Nov 30 2016 GLOBE NEWSWIRE Surefire Medical Inc today announced that Mats Wahlstrm is joining the companys Board of Directors and will serve as chairman Wahlstrm has more than 30 years of experience in the healthcare industry having served as CEO and CFO of large international..

Achillion Announces Initiation of Patient Dosing by Janssen in a Global, Short Treatment-Duration Phase 2b Study of JNJ-4178 in Chronic HCV

Wednesday, November 30, 2016
GLOBE NEWSWIRE

Janssen initiates dosing of patients in OMEGA1 Phase 2b study evaluating six and eightweek treatment durations with JNJ4178 a 3DAA combination of odalasvir simeprevir and AL335 for the treatment of chronic HCV NEW HAVEN Conn Nov 30 2016 GLOBE NEWSWIRE Achillion Pharmaceuticals IncNasdaqACH..

Tonix Pharmaceuticals to Present at 9th Annual LD Micro Main Event Investor Conference

Wednesday, November 30, 2016
GLOBE NEWSWIRE

NEW YORK Nov 30 2016 GLOBE NEWSWIRE Tonix Pharmaceuticals Holding Corp NasdaqTNXP Tonix which is developing a nextgeneration treatment for posttraumatic stress disorder PTSD announced today that it will present at the 9th Annual LD Micro Main Event being held December 67 2016 in Los Angeles ..

Viracta acquires Phase 2 epigenetic drug candidate from Chroma Therapeutics

Wednesday, November 30, 2016
GLOBE NEWSWIRE

SAN DIEGO and LONDON Nov 30 2016 GLOBE NEWSWIRE Viracta Therapeutics Inc announced completion of its acquisition of drug development candidate VRx3996 from Chroma Therapeutics Ltd Viracta plans to advance VRx3996 previously CHR3996 into Phase 2 clinical testing for application in Viractas pr..

Diabetes in the United States: Gallup and Healthways Rank 50 States and 190 Communities

Wednesday, November 30, 2016
GLOBE NEWSWIRE

WASHINGTON NASHVILLE Tenn Nov 30 2016 GLOBE NEWSWIRE Worldleading analytics and advice firm Gallup and global wellbeing improvement leaderHealthways a Sharecare company have released new research part of the GallupHealthways State of American WellBeing series that examines the incidence of d..

Dr. George E. Anastassov, Chief Executive Officer of AXIM® Biotech, Featured in Exclusive Interview with SmallCapVoice.com

Wednesday, November 30, 2016
GLOBE NEWSWIRE

AUSTIN Texas Nov 30 2016 GLOBE NEWSWIRE SmallCapVoicecom Inc SCV andAXIMBiotechnologies Inc AXIMBiotech OTCAXIM a world leader in cannabinoid research and development today announced that the Companys Chief Executive Officer George E Anastassov is featured in an audio interview at SmallCapVoic..

Expanded Options for Cancer Researchers with Leica Biosystems and Advanced Cell Diagnostics Automated RNA ISH Workflow with Powerful Aperio Image Analysis*

Wednesday, November 30, 2016
PR Newswire

VISTA California November 30 2016 PRNewswire Aperio RNA ISH Algorithm and BOND RX are for Research Use Only Not for use in diagnostic procedures Leica Biosystems and Advanced Cell Diagnostics ACD a BioTechne brand proudly announce the availability of the Aperio RNA ISH Algorithm for use with ..

Lyotropic Delivery Systems Introduces Bio-Enhanced CBD Products

Wednesday, November 30, 2016
PR Newswire

JERUSALEM November 30 2016 PRNewswire Revolutionary new technology gives cannabinoids unparalleled access to bloodstream Commercial launch by Ananada Scientific of HYGIA Nutrients Brand took place at the Marijuana Business Conference in Las Vegas Lyotropic Delivery Systems LDS Biotech today..

Lannett Provides Update On Methylphenidate ER Tablets

Wednesday, November 30, 2016
PR Newswire

PHILADELPHIA Nov 30 2016 PRNewswire Lannett Company Inc NYSE LCI today announced that the US Food and Drug Administration FDA granted the company a 90day extension to submit documentation concerning its Methylphenidate Hydrochloride HCl ExtendedRelease ER Tablets The new deadline for submitting th..

Abbott Announces CE Mark for i-STAT Alinity, a Pioneering, Handheld Blood Testing Platform

Wednesday, November 30, 2016
PR Newswire

ABBOTT PARK Ill Nov 30 2016 PRNewswire Abbott NYSE ABT announced today its iSTAT Alinity System an innovative handheld blood testing platform received CE Mark and is now for sale in Europe and other countries that recognize CE Mark The portable device can perform and analyze the largest menu of b..

Aralez to Participate at Two Upcoming Healthcare Conferences

Wednesday, November 30, 2016
PR Newswire

MISSISSAUGA Ontario Nov 30 2016 PRNewswire Aralez Pharmaceuticals Inc NASDAQ ARLZ TSX ARZa global specialty pharmaceutical companytoday announced that Adrian Adams Chief Executive Officer will participate in the following healthcare conferences Guggenheims OneonOne Healthcare Conference in Bosto..

Connecticut State Medical Society Supports Free Prescription Assistance Program

Wednesday, November 30, 2016
PR Newswire

NORTH HAVEN Conn Nov 30 2016 PRNewswire Connecticut State Medical Society CSMS has officially partnered with the Connecticut Drug Card in order to provide a FREE prescription assistance program to its patients employees and others The Connecticut Drug Card was launched in an effort to make prescri..

Sangamo\'s Genome Editing Program for Hemoglobinopathies to Transfer to Biogen\'s Spin-Off Bioverativ

Wednesday, November 30, 2016
PR Newswire

RICHMOND Calif Nov 30 2016 PRNewswire Sangamo BioSciences Inc Nasdaq SGMO a leader in therapeutic genome editing announced today that its collaborative zinc finger nuclease ZFNmediated genome editing program for hemoglobinopathies will transfer to Bioverativ Our collaboration with Biogen has bee..

VistaGen Therapeutics to Present at 9th Annual LD Micro Main Event

Wednesday, November 30, 2016
PR Newswire

SOUTH SAN FRANCISCO Calif Nov 30 2016 PRNewswire VistaGen Therapeutics Inc NASDAQ VTGN a clinicalstage biopharmaceutical company focused on developing new generation therapies for depression and other central nervous system CNS disorders today announced that Shawn Singh Chief Executive Officer wi..

Technical Reports on Healthcare Stocks -- Teva Pharma, Endo, Ionis Pharma, and Alimera Sciences

Wednesday, November 30, 2016
PR Newswire

NEW YORK November 30 2016 PRNewswire This morning StockCallerscom presents four equities to see how they have fared over the last few trading sessions Teva Pharmaceutical Industries Ltd NYSE TEVA Endo International PLC NASDAQ ENDP Ionis Pharmaceuticals Inc NASDAQ IONS and Alimera Sciences Inc NA..

Mallinckrodt To Present At BMO Capital Markets 2016 Prescriptions For Success Healthcare Conference

Wednesday, November 30, 2016
PR Newswire

CHESTERFIELD United Kingdom Nov 30 2016 PRNewswire Mallinckrodt Pharmaceuticals NYSE MNK a leading global specialty pharmaceutical company will present on Wednesday Dec 14 2016 at the BMO Capital Markets 2016 Prescriptions for Success Healthcare Conference at the Intercontinental Barclay 111 East ..

Research Reports Coverage on Biotech Stocks -- Biogen, BioMarin Pharma, Seattle Genetics, and Grifols

Wednesday, November 30, 2016
PR Newswire

NEW YORK November 30 2016 PRNewswire The Biotech arena might have experienced doubledigit declines earlier this year but following Trumps victory in the presidential election fund managers are now predicting an uptick in MA activities within the industry which should present some investment oppo..

Tempus Announces Collaboration with Abramson Cancer Center at Penn to Increase the Effectiveness of Immunotherapy Treatment

Wednesday, November 30, 2016
PR Newswire

CHICAGO Nov 30 2016 PRNewswire Tempus a technology company focused on supporting physicians delivering customized cancer care and Penns Abramson Cancer Center have partnered to better determine which patients will have a positive response to immunotherapy treatment based on next generation genomic..

TOP